Sitemap - 2025 - Microcap Opportunities
Portfolio Heats up to 42% Annual Return
Why An Insider Just Made a Huge Purchase of NeurAxis Shares
We Want To Be In Before the Bean Counters
NeurAxis (NRXS): A Steal at Current Market Price
Taking Profits on Gossamer Bio
Testing Support and Gapology are in Play
NeurAxis: A Vast Unrecognized Market Opportunity
The Steady Ascent of Aurora Spine: Is a Surge Coming?
Technical Analysis Should Not Be Overlooked
How We Are Doing on Our Aim for 30% Annualized Return
MicroCap Opportunities End of the Month Report - May 2025
Microcap Opportunities - April 2025 Portfolio Return Update
Axil Brands Adds Hearing Enhancement To Hearing Protection
End of April 2025 Portfolio Review
Ascent Industries Value Propulsion Amid Tariff Madness
CNTB - Closing Position After Run-Up
WidePoint Aligns With DOGE Objective
End Of March 2025 Portfolio Review
Aurora Spine's AERO FDA Approval is a Potential Big Catalyst
Nexalin Technology Is Ramping Up Commercial Activity
VSee Health - A Next-Gen Digital Healthcare Platform
End Of February 2025 Portfolio Review
Cardiol Therapeutics - Bargain Stock Price And Share Price Appreciation Catalysts
Coya Therapeutics Halts Progression of Alzheimers in Small Study
Microcap Opportunities - January Portfolio Return Update
End Of January 2025 Portfolio Review
NeurAxis Has Crafted An Inflection Point
Frequency Electronics and Quantum Sensors
Clarification Alert on Portfolio Company NRXS
VSee: Building of a Next Generation Telehealth Company
Delcath Has A Path To Profitability
TAT Technologies Catching Aviation Tailwinds
Microcap Opportunities 2024 Year-End Return - 126.7% Annualized!